⌘K

Login Start Free

Home/Filings/4/0001144204-13-032401

4//SEC Filing

Tolliver Kei S 4

Accession 0001144204-13-032401

CIK 0001365216other

View on SEC.gov Company Profile

Filed

May 29, 8:00 PM ET

Accepted

May 30, 5:07 PM ET

Size

5.0 KB

Accession

0001144204-13-032401

Insider Transaction Report

Form 4

Period: 2013-05-22

Sucampo Pharmaceuticals, Inc.SCMP

Director

Transactions

Award
Director Stock Option (Right to Buy)
2013-05-22+30,000→ 30,000 total
Exercise: $8.62Exp: 2023-05-22→ Class A Common Stock (30,000 underlying)

Footnotes (1)

[F1]The options vest in twelve equal quarterly installments.

Documents

1 file

4
form460082_20130530050649-.xmlPrimary

Issuer

Sucampo Pharmaceuticals, Inc.

CIK 0001365216

Entity typeother

Related Parties

1

filerCIK 0001383286

Filing Metadata

Form type: 4
Filed: May 29, 8:00 PM ET
Accepted: May 30, 5:07 PM ET
Size: 5.0 KB

View on SEC.gov